NO891929D0 - Nye komposisjoner med loeselige signalmolekyler for in vitro overvaaking av diabetes mellitus. - Google Patents

Nye komposisjoner med loeselige signalmolekyler for in vitro overvaaking av diabetes mellitus.

Info

Publication number
NO891929D0
NO891929D0 NO891929A NO891929A NO891929D0 NO 891929 D0 NO891929 D0 NO 891929D0 NO 891929 A NO891929 A NO 891929A NO 891929 A NO891929 A NO 891929A NO 891929 D0 NO891929 D0 NO 891929D0
Authority
NO
Norway
Prior art keywords
signal
haemoglobin
pct
bound
sample
Prior art date
Application number
NO891929A
Other languages
English (en)
Inventor
Erling Sundrehagen
Original Assignee
Axis Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NO890029A priority Critical patent/NO890029D0/no
Application filed by Axis Research filed Critical Axis Research
Priority to NO891929A priority patent/NO891929D0/no
Publication of NO891929D0 publication Critical patent/NO891929D0/no
Priority to NO901643A priority patent/NO901643D0/no
Priority to BR909007357A priority patent/BR9007357A/pt
Priority to AU56670/90A priority patent/AU642879B2/en
Priority to PCT/EP1990/000820 priority patent/WO1990013818A1/en
Priority to AT90908231T priority patent/ATE117806T1/de
Priority to EP90908231A priority patent/EP0471774B1/en
Priority to JP2507703A priority patent/JPH0812196B2/ja
Priority to DK90908231.5T priority patent/DK0471774T3/da
Priority to US07/613,505 priority patent/US5242842A/en
Priority to HU904320A priority patent/HU215181B/hu
Priority to DE69016423T priority patent/DE69016423T2/de
Priority to CA002055430A priority patent/CA2055430C/en
Priority to SU5010459A priority patent/RU2111494C1/ru
Priority to ES90908231T priority patent/ES2067029T3/es
Priority to KR1019910701571A priority patent/KR960010697B1/ko
Priority to NO914372A priority patent/NO302784B1/no
Priority to FI915284A priority patent/FI100437B/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO891929A 1989-01-04 1989-05-11 Nye komposisjoner med loeselige signalmolekyler for in vitro overvaaking av diabetes mellitus. NO891929D0 (no)

Priority Applications (19)

Application Number Priority Date Filing Date Title
NO890029A NO890029D0 (no) 1989-01-04 1989-01-04 Nye modifiserte peptider og proteiner for in vitro diagnoser (diabetes).
NO891929A NO891929D0 (no) 1989-01-04 1989-05-11 Nye komposisjoner med loeselige signalmolekyler for in vitro overvaaking av diabetes mellitus.
NO901643A NO901643D0 (no) 1989-05-11 1990-04-11 Ligand bindingstest med signalgivende molekyl for spesifikk kvantifisering av glykosylert hemoglobin i blandinger inneholdende andre glykosylerte proteiner og/eller glykoproteiner og/eller karbohydrater.
KR1019910701571A KR960010697B1 (ko) 1989-05-11 1990-05-11 글리코실화된 헤모글로빈의 분석법
JP2507703A JPH0812196B2 (ja) 1989-05-11 1990-05-11 グリコシル化ヘモグロビンのアッセイ
US07/613,505 US5242842A (en) 1989-05-11 1990-05-11 Glycosylated haemoglobin assay
PCT/EP1990/000820 WO1990013818A1 (en) 1989-05-11 1990-05-11 Glycosylated haemoglobin assay
AT90908231T ATE117806T1 (de) 1989-05-11 1990-05-11 Bestimmungsmethode für glykosyliertes hämoglobin.
EP90908231A EP0471774B1 (en) 1989-05-11 1990-05-11 Glycosylated haemoglobin assay
BR909007357A BR9007357A (pt) 1989-05-11 1990-05-11 Processo para analise de hemoglobina glicosilada em uma amostra,reagente,processo para a precipitacao de hemoglobina a partir de uma solucao homogenea,e,estojo para teste analitico
DK90908231.5T DK0471774T3 (da) 1989-05-11 1990-05-11 Assay for glycosyleret hæmoglobin
AU56670/90A AU642879B2 (en) 1989-05-11 1990-05-11 Glycosylated haemoglobin assay
HU904320A HU215181B (hu) 1989-05-11 1990-05-11 Eljárás és vizsgálókészlet glükozilált hemoglobin kimutatására
DE69016423T DE69016423T2 (de) 1989-05-11 1990-05-11 Bestimmungsmethode für glykosyliertes hämoglobin.
CA002055430A CA2055430C (en) 1989-05-11 1990-05-11 Glycosylated haemoglobin assay
SU5010459A RU2111494C1 (ru) 1989-05-11 1990-05-11 Способ определения гликолизированного гемоглобина в присутствии негликолизированного гемоглобина, аналитический тестовый набор
ES90908231T ES2067029T3 (es) 1989-05-11 1990-05-11 Ensayo de hemoglobina glicosilada.
FI915284A FI100437B (fi) 1989-05-11 1991-11-08 Glykosyloituneen hemoglobiinin määritys
NO914372A NO302784B1 (no) 1989-05-11 1991-11-08 Fremgangsmåte ved påvisning av glykosylert hemoglobin samt sett og reagens for utförelse av fremgangsmåten

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO890029A NO890029D0 (no) 1989-01-04 1989-01-04 Nye modifiserte peptider og proteiner for in vitro diagnoser (diabetes).
NO891929A NO891929D0 (no) 1989-01-04 1989-05-11 Nye komposisjoner med loeselige signalmolekyler for in vitro overvaaking av diabetes mellitus.

Publications (1)

Publication Number Publication Date
NO891929D0 true NO891929D0 (no) 1989-05-11

Family

ID=19892012

Family Applications (4)

Application Number Title Priority Date Filing Date
NO890029A NO890029D0 (no) 1989-01-04 1989-01-04 Nye modifiserte peptider og proteiner for in vitro diagnoser (diabetes).
NO891929A NO891929D0 (no) 1989-01-04 1989-05-11 Nye komposisjoner med loeselige signalmolekyler for in vitro overvaaking av diabetes mellitus.
NO901643A NO901643D0 (no) 1989-05-11 1990-04-11 Ligand bindingstest med signalgivende molekyl for spesifikk kvantifisering av glykosylert hemoglobin i blandinger inneholdende andre glykosylerte proteiner og/eller glykoproteiner og/eller karbohydrater.
NO914372A NO302784B1 (no) 1989-05-11 1991-11-08 Fremgangsmåte ved påvisning av glykosylert hemoglobin samt sett og reagens for utförelse av fremgangsmåten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO890029A NO890029D0 (no) 1989-01-04 1989-01-04 Nye modifiserte peptider og proteiner for in vitro diagnoser (diabetes).

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO901643A NO901643D0 (no) 1989-05-11 1990-04-11 Ligand bindingstest med signalgivende molekyl for spesifikk kvantifisering av glykosylert hemoglobin i blandinger inneholdende andre glykosylerte proteiner og/eller glykoproteiner og/eller karbohydrater.
NO914372A NO302784B1 (no) 1989-05-11 1991-11-08 Fremgangsmåte ved påvisning av glykosylert hemoglobin samt sett og reagens for utförelse av fremgangsmåten

Country Status (16)

Country Link
US (1) US5242842A (no)
EP (1) EP0471774B1 (no)
JP (1) JPH0812196B2 (no)
KR (1) KR960010697B1 (no)
AT (1) ATE117806T1 (no)
AU (1) AU642879B2 (no)
BR (1) BR9007357A (no)
CA (1) CA2055430C (no)
DE (1) DE69016423T2 (no)
DK (1) DK0471774T3 (no)
ES (1) ES2067029T3 (no)
FI (1) FI100437B (no)
HU (1) HU215181B (no)
NO (4) NO890029D0 (no)
RU (1) RU2111494C1 (no)
WO (1) WO1990013818A1 (no)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807747A (en) * 1989-06-13 1998-09-15 Clinical Innovations Limited Method and apparatus for determination of glycosylated protein
US5403745A (en) * 1990-04-27 1995-04-04 Genzyme Corporation Determination of analytes in biological fluids in the presence of substances interfering with assays therefor
US5135875A (en) * 1990-08-15 1992-08-04 Abbott Laboratories Protein precipitation reagent
GB9024771D0 (en) * 1990-11-14 1991-01-02 Axis Research Assay
GB9024775D0 (en) * 1990-11-14 1991-01-02 Axis Research Chemical compounds
DE4206932A1 (de) * 1992-03-05 1993-09-09 Boehringer Mannheim Gmbh Immunologische methode zur bestimmung eines haemoglobinderivates
US5512451A (en) * 1993-04-01 1996-04-30 British Technology Group Limited Enhancement of chemiluminescent reactions
ES2158085T3 (es) * 1994-01-28 2001-09-01 Prolinx Inc Complejos de acido fenilboronico.
US5594151A (en) * 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexing reagents derived from aminosalicylic acid
US5744627A (en) * 1994-01-28 1998-04-28 Prolinx, Inc. Boronic compound complexing reagents and complexes
US5847192A (en) * 1994-01-28 1998-12-08 Prolinx, Inc. Boronic compound complexing reagents and complexes
US5852178A (en) * 1994-01-28 1998-12-22 Prolinx, Inc. Phenylboronic acid complexing reagents for conjugating biologically active molecules
US5594111A (en) * 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexes for bioconjugate preparation
US5623055A (en) * 1994-01-28 1997-04-22 Prolinx, Inc. Phenylboronic acid complexes derived from aminosalicylic acid for bioconjugate preparation
US5777148A (en) * 1994-01-28 1998-07-07 Prolinx, Inc. Boronic compound complexing reagents and highly stable complexes
US5837878A (en) * 1994-01-28 1998-11-17 Prolinx, Inc. Boronic compound complexing reagents and highly stable complexes
US5631364A (en) * 1994-03-31 1997-05-20 Axis Biochemicals Asa Labelled boronic acid derivatives
GB9415143D0 (en) * 1994-07-27 1994-09-14 Edwards Raymond Glycated haemoglobin assay
AU3953595A (en) * 1994-10-07 1996-05-02 Merck & Co., Inc. Process for assessing tubulin protein polymerization
US5695949A (en) * 1995-04-07 1997-12-09 Lxn Corp. Combined assay for current glucose level and intermediate or long-term glycemic control
GB9508278D0 (en) * 1995-04-24 1995-06-14 Axis Biochemicals As Haemoglobin standards
JP3269765B2 (ja) * 1995-12-14 2002-04-02 富士写真フイルム株式会社 ヘモグロビン誘導体の免疫学的測定方法及びその方法に用いる処理試薬
US6001573A (en) * 1996-06-14 1999-12-14 Packard Bioscience B.V. Use of porphyrins as a universal label
US6156884A (en) 1996-08-05 2000-12-05 Prolinx, Inc. Bifunctional boronic compound complexing reagents and complexes
US6075126A (en) * 1996-08-05 2000-06-13 Prolinx, Inc. Phenyldiboronic acid reagents and complexes
US6162645A (en) * 1997-03-13 2000-12-19 Abbott Laboratories Determination of % glycated hemoglobin
US6316265B1 (en) 1997-03-13 2001-11-13 Abbott Laboratories Determination of % glycated hemoglobin
DE19843094A1 (de) * 1998-09-21 2000-03-23 Roche Diagnostics Gmbh Verfahren zur Bestimmung von glykiertem Hämoglobin
DE19856433C2 (de) * 1998-12-08 2001-09-13 Aventis Behring Gmbh Verfahren zum spezifischen Nachweis von glykosilierten Proteinen
US7470420B2 (en) * 2000-12-05 2008-12-30 The Regents Of The University Of California Optical determination of glucose utilizing boronic acid adducts
US6653141B2 (en) 2000-12-05 2003-11-25 The Regents Of The University Of California Polyhydroxyl-substituted organic molecule sensing method and device
US6627177B2 (en) * 2000-12-05 2003-09-30 The Regents Of The University Of California Polyhydroxyl-substituted organic molecule sensing optical in vivo method utilizing a boronic acid adduct and the device thereof
US7195923B2 (en) * 2001-01-31 2007-03-27 Scripps Laboratories, Inc. Ratiometric determination of glycated protein
GB0110053D0 (en) * 2001-04-24 2001-06-13 Axis Shield Asa Assay
US6852503B1 (en) * 2001-05-30 2005-02-08 Pierce Biotechnology, Inc. Compositions and methods for utilizing mixed substrate solutions of luminols and dioxetanes
US7670853B2 (en) * 2002-11-05 2010-03-02 Abbott Diabetes Care Inc. Assay device, system and method
US7390670B2 (en) 2003-02-20 2008-06-24 Lumigen, Inc. Signalling compounds and methods for detecting hydrogen peroxide
CA2514010A1 (en) * 2004-08-03 2006-02-03 Axis-Shield Diagnostics Limited Assay
US20110136157A1 (en) * 2005-04-25 2011-06-09 Garth James Smith Cooper Copper regulation evaluation and therapy
GB2436681B (en) * 2006-03-31 2010-10-13 Quotient Diagnostics Ltd Fluorescent assay
WO2007127616A2 (en) * 2006-04-12 2007-11-08 Benjamin Pless Cavitation heating system and method
EP2047272B1 (en) * 2006-07-29 2014-10-22 i-Sens, Inc. Electrochemical determination system of glycated proteins
KR101005559B1 (ko) 2008-07-15 2011-01-05 주식회사 아이센스 바이오센서를 이용한 단백질 측정 장치
BRPI0914373A2 (pt) * 2008-10-14 2015-10-20 Piramal Healthcare Ltd "método eletroquímico não-enzimático para determinação simultânea de hemoglobina total e hemoglibina glicosilada"
WO2010147251A1 (ko) 2009-06-19 2010-12-23 주식회사 인포피아 당화혈색소 측정 방법
EP2805164B1 (en) * 2012-01-16 2017-11-08 Koninklijke Philips N.V. Determining a presence of target molecules in a body fluid comprising cells
GB201215571D0 (en) 2012-08-31 2012-10-17 Axis Shield Asa Assay method
KR20140032221A (ko) * 2012-09-06 2014-03-14 삼성전자주식회사 시료 중의 당화 단백질을 확인하는 방법 및 그를 위한 장치
RU2612092C1 (ru) * 2015-12-08 2017-03-02 Федеральное государственное бюджетное учреждение "Российский кардиологический научно-производственный комплекс" Министерства здравоохранения Российской Федерации (ФГБУ "РКНПК" Минздрава России) Способ диагностики сахарного диабета по уровню метилглиоксаль-модифицированных липопротеидов низкой плотности с использованием моноклональных антител
CN107153121B (zh) * 2017-04-12 2019-03-08 深圳市东邦生物医疗技术有限公司 糖化血红蛋白、血红蛋白检测试剂盒及其检测方法
CN115825293B (zh) * 2023-02-21 2023-10-13 艾康生物技术(杭州)有限公司 一种用于糖化血红蛋白测试的试剂盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4269605A (en) * 1978-06-28 1981-05-26 Amicon Corporation Method and kit for separation of glycoproteins
US4268270A (en) * 1979-04-30 1981-05-19 Children's Hospital Medical Center Glycosylated hemoglobin measurement
FR2464475A1 (fr) * 1979-08-30 1981-03-06 Amicon Corp Procede et produit pour la separation des glycoproteines et leur application notamment a la determination de l'hemoglobine glycosylee
JPS5640694A (en) * 1979-09-06 1981-04-16 Amicon Corp Method of separating glycoprotein and chemical agent therefor
US4371374A (en) * 1980-11-17 1983-02-01 The Rockefeller University Monitoring metabolic control in diabetic patients by measuring glycosylated amino acids and peptides in urine
US4407961A (en) * 1981-03-16 1983-10-04 Sanders James L Ion-exchange system and method for isolation and determination of glycosylated hemoglobin in human blood
US4659817A (en) * 1981-05-01 1987-04-21 The Children's Medical Center Corporation Reporter compounds containing boron
GB8504521D0 (en) * 1985-02-21 1985-03-27 Genetics Int Inc Electrochemical assay
US4861728A (en) * 1987-07-24 1989-08-29 Becton, Dickinson And Company Immunoassay of glycosylated hemoglobin using a labeled boron reagent
US5137833A (en) * 1989-09-21 1992-08-11 Russell Anthony P Method for detecting polyhydroxyl compounds

Also Published As

Publication number Publication date
KR960010697B1 (ko) 1996-08-07
US5242842A (en) 1993-09-07
NO914372L (no) 1992-01-09
FI100437B (fi) 1997-11-28
DE69016423T2 (de) 1995-06-14
KR920701824A (ko) 1992-08-12
JPH0812196B2 (ja) 1996-02-07
EP0471774B1 (en) 1995-01-25
FI915284A0 (fi) 1991-11-08
HUT66835A (en) 1995-01-30
EP0471774A1 (en) 1992-02-26
CA2055430C (en) 1999-08-31
AU5667090A (en) 1990-11-29
HU904320D0 (en) 1992-02-28
NO302784B1 (no) 1998-04-20
BR9007357A (pt) 1992-04-21
NO901643D0 (no) 1990-04-11
NO890029D0 (no) 1989-01-04
NO914372D0 (no) 1991-11-08
DK0471774T3 (da) 1995-03-20
AU642879B2 (en) 1993-11-04
DE69016423D1 (de) 1995-03-09
CA2055430A1 (en) 1990-11-12
JPH04506703A (ja) 1992-11-19
WO1990013818A1 (en) 1990-11-15
HU215181B (hu) 1998-10-28
ES2067029T3 (es) 1995-03-16
RU2111494C1 (ru) 1998-05-20
ATE117806T1 (de) 1995-02-15

Similar Documents

Publication Publication Date Title
NO891929D0 (no) Nye komposisjoner med loeselige signalmolekyler for in vitro overvaaking av diabetes mellitus.
Brennan Changes in solubility, non-enzymatic glycation, and fluorescence of collagen in tail tendons from diabetic rats
US5529899A (en) Immunoassay for AH receptor transformed by dioxin-like compounds
CA2096250A1 (en) Assay for glycated blood proteins
EP0752426A2 (de) Synthetische Kalibratoren für den Einsatz in Immunoassays, bestehend aus Analyten oder Teilsequenzen davon, die an inerte Trägermoleküle konjugiert sind
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
ES2104558T3 (es) Glicoesfingolipidos con un grupo acoplable en la porcion esfingoide, su preparacion y utilizacion.
EP0407904A2 (de) Verfahren zur Bestimmung eines Analyten
EP0291086B1 (de) Verfahren zur Bestimmung eines Antikörpers in menschlichen Körperflüssigkeiten
DE69524576D1 (de) Küvette für eine analysevorrichtung, verfahren und diagnostischer testsatz zur feststellung von analyten in vollblutproben
WO2001057537A3 (en) Methods for diagnosis of alzheimer's disease
Nelson et al. Preparation and characterization of diaspirin cross-linked hemoglobin solutions for preclinical studies
DK1043587T3 (da) Fremgangsmåde til undersøgelse af nyresygdomme
ATE80948T1 (de) Diagnostisches immuntest-verfahren mittels festphasenabscheidung.
Rasberry Biological reference materials from the US National Bureau of Standards—An update
SU1175442A1 (ru) Способ диагностики гипоксии мозга у новорожденных
JP2000065839A (ja) ヒトヘモグロビン検出装置
JPS6486067A (en) Diagnosis and kit for bloom syndrome
Chew et al. Evaluation of Sealands Using Infrared Spectroscopy
EP0444561A2 (de) Verfahren zur immunologischen Bestimmung von Liganden
DE69123443D1 (de) Verfahren zur diagnose der komplexen urolithiase und prognose der urolithiase
RU1805391C (ru) Способ биохимического исследовани компонентов соединительной ткани
RU2013773C1 (ru) Способ определения гликемии в трупной крови
Jones PC shunt and lipid biosynthesis
Goldwasser Studies of the biochemical regulation of blood cell formation. Final report, January 1-September 30, 1980